Quantcast

Red clover found to battle prostate cancer

An Australian study has found that a supplement derived from red clover causes early-stage prostate cancer cells to die in numbers five times greater than in an untreated control group. The findings may explain the mystery of why Asian men, who have pre-cancerous prostate cells at similar rates to men in Western countries, see a much smaller percentage of those cells become cancerous. One previously reported study, for example, finds that 1.8 percent of men in China develop prostate cancer versus 53.4 percent of U.S. males. These findings led researchers to consider dietary differences between the cultures, particularly isoflavones.